- Correction
- Open Access
Correction to: Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population
- Published: 21 January 2019
The original article was published in Infectious Agents and Cancer 2017 12:2
Correction to: Infectious Agents and Cancer 2017 12:2 DOI https://doi.org/10.1186/s13027-016-0114-5
reports the prevalence of cervical abnormalities observed in the sample (N = 599)
Cytological status | n | % of FSW (95%CI) |
---|---|---|
Normal cytology | 512 | 85.5% (82.4–88.2) |
ASC-US | 10 | 1.7% (0.8–3.04) |
LSIL | 63 | 10.5% (8.2–13.3) |
HSIL | 14 | 2.3% (12.8–3.9) |
Excluded samples due to poor cell quality | 17 | 2.8% |
reports the prevalence of each HPV genotypes and STIs
pHR/ HR HPV Genotype | Frequency (n) | Percentage |
---|---|---|
HPV 16 (N = 616) | 99 | 16.1% |
HPV 18 (N = 616) | 68 | 11.0% |
HPV 31 (N = 616) | 49 | 8.0% |
HPV 33 (N = 616) | 2 | 0.3% |
HPV 35 (N = 616) | 70 | 11.4% |
HPV 39 (N = 616) | 48 | 7.8% |
HPV 51 (N = 615) | 52 | 8.5% |
HPV 53 (N = 616) | 68 | 11.0% |
HPV 56 (N = 616) | 45 | 7.3% |
HPV 58 (N = 616) | 30 | 4.9% |
HPV 59 (N = 616) | 75 | 12.2% |
HPV 66 (N = 616) | 60 | 9.7% |
HPV 68 (N = 616) | 9 | 1.5% |
BV and STIs | ||
BV* (N = 555) | 268 | 48.3% |
TV (N = 609) | 191 | 31.4% |
Candida (N = 609) | 121 | 19.9% |
reports the prevalence of each HPV genotype among HPV-positive women with abnormal cytology
HPV genotype | Abnormal cytology | % (N = 84) |
---|---|---|
HPV 16 | 24 | 28.6% |
HPV 18 | 15 | 17.9% |
HPV 31 | 13 | 15.5% |
HPV 33 | 1 | 1.2% |
HPV 35 | 18 | 21.4% |
HPV 39 | 13 | 15.5% |
HPV 45 | 9 | 10.7% |
HPV 51 | 18 | 21.4% |
HPV 52 | 26 | 31.0% |
HPV 53 | 21 | 25.0% |
HPV 56 | 13 | 15.5% |
HPV 58 | 4 | 4.8% |
HPV 59 | 17 | 20.2% |
HPV 66 | 9 | 10.7% |
HPV 68 | 4 | 4.8% |
most prevalent pairing occurrences in women with abnormal cytology
Prevalent pairings in abnormal cytology in HIV-negative women: N = 35) | (n = in normal cytology) | n = abnormal cytology |
---|---|---|
HPV 18 and 31 | 2 | 3 |
HPV 31 and 52 | 7 | 2 |
Prevalent pairings in HIV infected women with abnormal cytology: N = 52) | ||
HPV 16 and 39 | 2 | 6 |
HPV 16 and 52 | 9 | 7 |
HPV 16 and 51 | 4 | 5 |
HPV 16 and 53 | 10 | 7 |
HPV 18 and 52 | 12 | 5 |
HPV 18 and 53 | 8 | 5 |
HPV 31 and 51 | 2 | 5 |
HPV 35 and 51 | 2 | 5 |
HPV 35 and 53 | 4 | 7 |
HPV 45 and 53 | 0 | 6 |
HPV 45 and 59 | 2 | 5 |
HPV 51 and 53 | 2 | 7 |
HPV 51 and 56 | 1 | 6 |
HPV 52 and 56 | 3 | 6 |
HPV 53 and 56 | 1 | 5 |
association between STI, specific pHR/HR HPV genotypes and abnormal cytology; OR from
STI or HPV genotype | OR Model 1 (95%CI) | p-value | OR Model 2 (95%CI) | p-value |
---|---|---|---|---|
BV | 0.9 (0.6–1.5) | 0.8 | 0.8 (0.5–1.4) | 0.5 |
TV | 24.8 (12.7–48.3) | < 0.001 | 30.0 (14.1–62.9) | < 0.001 |
Candida spp | 1.0 (0.5–1.7) | 1.0 | 0.9 (0.5–1.7) | 0.7 |
Multiple HPV infection | 5.3 (2.9–9.7) | < 0.001 | 3.7 (1.9–7.3) | < 0.001 |
HPV 16 | 1.9 (0.8–4.5) | 0.1 | 1.2 (0.5–3.2) | 0.5 |
HPV 18 | 0.8 (0.3–2.1) | 0.7 | 1.04 (0.4–2.8) | 0.9 |
HPV 31 | 0.5 (0.2–1.5) | 0.2 | 0.6 (0.2–1.7) | 0.3 |
HPV 33 | 3.9 (0.05–293.9) | 0.5 | 2.8 (0.03–254.6) | 0.6 |
HPV 35 | 1.3 (0.6–3.0) | 0.5 | 1.1 (0.5–2.7) | 0.9 |
HPV 39 | 3.3 (1.3–8.7) | 0.03 | 2.5 (0.9–7.1) | 0.09 |
HPV 51 | 3.7 (1.6–8.6) | 0.002 | 3.7 (1.5–9.0) | 0.004 |
HPV 52 | 6.1 (2.8–13.3) | < 0.001 | 4.0 (1.6–8.2) | 0.002 |
HPV 53 | 2.0 (0.8–4.9) | 0.1 | 1.4; (0.5–3.8) | 0.5 |
HPV 56 | 2.5 (1.0–6.6) | 0.06 | 2.0 (0.7–5.7) | 0.2 |
HPV 58 | 0.9 (0.2–3.6) | 0.9 | 1.1 (0.3–5.2) | 0.9 |
HPV 66 | 1.2 (0.5–3.0) | 0.7 | 1.0 (0.4–3.0) | 0.9 |
HPV 68 | 1.7 (0.2–17.0) | 0.7 | 0.8 (0.1–7.4) | 0.8 |
Notes
Declarations
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Authors’ Affiliations
Reference
- Menon S, et al. Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population. Infect Agent Cancer. 2017;12(2). https://doi.org/10.1186/s13027-016-0114-5.